Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. (Q54699022)

3 June 2018

title

Connexin43 promotes survival of mesenchymal stem cells in ischaemic heart. (English)

1 reference

3 June 2018

main subject

mesenchymal stem cell

1 reference

Deguo Wang

1

1 reference

3 June 2018

Wenzhi Shen

2

1 reference

3 June 2018

Fengxiang Zhang

3

1 reference

3 June 2018

Minglong Chen

4

1 reference

3 June 2018

Hongwu Chen

5

1 reference

3 June 2018

Kejiang Cao

6

1 reference

3 June 2018

publication date

12 March 2010

1 reference

3 June 2018

Cell Biology International

published in

1 reference

3 June 2018

volume

34

1 reference

3 June 2018

issue

4

1 reference

3 June 2018

page(s)

415-423

1 reference

3 June 2018

Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts.

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Allogeneic mesenchymal stem cell transplantation in postinfarcted rat myocardium: short- and long-term effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Electrical remodeling contributes to complex tachyarrhythmias in connexin43-deficient mouse hearts

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Apoptosis: a review of programmed cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Connexin 43 confers resistance to hydrogen peroxide-mediated apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Cardiac mitochondrial connexin 43 regulates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Forced myocardin expression enhances the therapeutic effect of human mesenchymal stem cells after transplantation in ischemic mouse hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Myoblasts transplanted into rat infarcted myocardium are functionally isolated from their host

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Bcl-2 Engineered MSCs Inhibited Apoptosis and Improved Heart Function

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Sca-1+ stem cell survival and engraftment in the infarcted heart: dual role for preconditioning-induced connexin-43.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Effective engraftment but poor mid-term persistence of mononuclear and mesenchymal bone marrow cells in acute and chronic rat myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Transplantation of mesenchymal stem cells improves cardiac function in a rat model of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Bone marrow stromal cells improve cardiac performance in healed infarcted rat hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Progressive increase in conduction velocity across human mesenchymal stem cells is mediated by enhanced electrical coupling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Connexin 43 as a signaling platform for increasing the volume and spatial distribution of regenerated tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Prospective randomized trial of direct endomyocardial implantation of bone marrow cells for treatment of severe coronary artery diseases (PROTECT-CAD trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Comparison of transplantation of adipose tissue- and bone marrow-derived mesenchymal stem cells in the infarcted heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Osteogenic differentiation of noncultured immunoisolated bone marrow-derived CD105+ cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Cardiomyocytes can be generated from marrow stromal cells in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCBI20090118

21 January 2018

Identifiers

DOI

10.1042/CBI20090118

1 reference

3 June 2018

PubMed ID

20067445

1 reference

3 June 2018